Eisai - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEisai

Eisai

Eisai Co., Ltd. (Japanese: エーザイ株式会社, Hepburn: Ēzai Kabushiki-gaisha) is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aricept	Donepezil	1996-11-25	2025-2038	Alzheimer disease
Banzel	Rufinamide	2008-11-14		Epilepsy , Seizures
Dayvigo	Lemborexant	2020-04-07	2031-2035	Sleep initiation and maintenance disorders
Fycompa	Perampanel	2012-07-23	2024-2026	Seizures, Partial epilepsies, Tonic-clonic epilepsy
Halaven	Eribulin	2010-11-15	2023-2027	Breast neoplasms, Liposarcoma
Hexalen	Altretamine	1990-12-26		Ovarian neoplasms
Inovelon	Rufinamide	2007-01-16		Epilepsy, Seizures
Kisplyx	Lenvatinib	2016-08-25	2025-2036	Renal cell carcinoma, Thyroid neoplasms
Lenvima	Lenvatinib	2015-02-13	2025-2036	Renal cell carcinoma, Thyroid neoplasms

1

2

>

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

healthy volunteers/patients

,

,

renal insufficiency

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

myeloproliferative disorders

,

non-hodgkin lymphoma

,

primary myelofibrosis

,

multiple myeloma

,

precursor cell lymphoblastic leukemia-lymphoma

,

b-cell chronic lymphocytic leukemia

,

bcr-abl positive chronic myelogenous leukemia

,

myelomonocytic leukemia chronic

,

,

hodgkin disease

,

leukemia myeloid chronic atypical bcr-abl negative

,

myelodysplastic-myeloproliferative diseases

,

myeloid leukemia chronic-phase

,

myeloid leukemia accelerated phase

,

,

,

rectal neoplasms

,

head and neck neoplasms

,

hepatic insufficiency

,

severity of illness index

,

biliary tract neoplasms

,

,

triple negative breast neoplasms

,

small cell lung carcinoma

,

neuroendocrine tumors

,

anaplastic thyroid carcinoma

,

esophageal neoplasms

,

pancreatic neoplasms

,

,

adenoid cystic carcinoma

,

neuroendocrine carcinoma

,

ovarian epithelial carcinoma

,

neoadjuvant therapy

,

gallbladder neoplasms

,

,

papillary thyroid cancer

,

follicular adenocarcinoma

,

,

molecular targeted therapy

,

clear cell adenocarcinoma

,

glandular and epithelial neoplasms

,

brain neoplasms

,

venous thrombosis

,

squamous cell neoplasms

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

pheochromocytoma

,

,

central nervous system neoplasms

,

gastrointestinal stromal tumors

,

fallopian tube neoplasms

,

therapeutic chemoembolization

,

female genital neoplasms

,

malignant mesothelioma

,

,

salivary gland neoplasms

,

papillary carcinoma

,

disease progression

,

merkel cell carcinoma

,

pancreatic ductal carcinoma

,

urinary bladder neoplasms

,

vulvar neoplasms

,

uveal neoplasms

,

adenomyoepithelioma

,

thymus neoplasms

,

,

carcinoid tumor

,

endocrine gland neoplasms

,

multiple endocrine neoplasia type 1

,

multiple endocrine neoplasia

,

meningeal carcinomatosis

,

papillomaviridae

,

,

urogenital neoplasms

,

hypersensitivity

,

ovarian diseases

,

,

,

,

adenocarcinoma of lung

,

,

gene rearrangement

,

vaginal neoplasms

,

adrenocortical carcinoma

,

serous cystadenocarcinoma

,

,

,

,

contraceptive effectiveness

,

endometrioid carcinoma

,

,

,

herpesviridae infections

,

second primary neoplasms

,

colonic neoplasms

,

hemangiosarcoma

,

preoperative period

,

,

,

non-small-cell lung carcinoma

,

,

neoplasm metastasis

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

colorectal neoplasms

,

uterine cervical neoplasms

,

esophageal squamous cell carcinoma

,

liver transplantation

,

urologic neoplasms

,

,

hematologic neoplasms

,

,

transitional cell carcinoma

,

hepatocellular carcinoma

,

,

liver neoplasms

,

,

renal cell carcinoma

,

cholangiocarcinoma

,

thyroid neoplasms

,

thyroid diseases

,

endometrial neoplasms

,

stomach neoplasms

,

breast neoplasms

,

,

ovarian neoplasms

,

,

kidney neoplasms

,

,

catheter ablation

,

digestive system neoplasms

,

liver cirrhosis

,

,

medullary carcinoma

,

gastrointestinal neoplasms

,

progression-free survival

,

,

hepatic encephalopathy

,

radiofrequency ablation

,

,

gender identity

,

,

,

portal hypertension

,

machine learning

healthy volunteers/patients

,

,

peripheral nerve injuries

,

anxiety disorders

,

generalized anxiety disorder

,

lennox gastaut syndrome

,

,

,

complex partial epilepsy

,

,

intellectual disability

,

drug resistant epilepsy

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

t-cell lymphoma cutaneous

healthy volunteers/patients

,

migraine disorders

,

,

,

,

,

parkinson disease

,

alzheimer disease

,

,

cognitive dysfunction

,

lewy body disease

,

cerebrovascular disorders

,

vascular dementia

,

chronic kidney failure

,

kidney diseases

,

memory disorders

,

,

mixed dementias

healthy volunteers/patients

,

chronic obstructive pulmonary disease

,

,

respiration disorders

,

obstructive lung diseases

,

renal insufficiency

,

,

hepatic insufficiency

,

obstructive sleep apnea

,

sleep apnea syndromes

,

,

opioid-related disorders

,

substance-related disorders

,

,

drug interactions

,

sleep wake disorders

,

,

emergence delirium

,

feasibility studies

,

cardiac surgical procedures

,

hospital mortality

,

,

,

major depressive disorder

,

mental disorders

,

depressive disorder

,

problem behavior

,

,

,

,

sleep initiation and maintenance disorders

,

alzheimer disease

,

,

circadian rhythm sleep disorders

,

,

pick disease of the brain

,

,

,

frontotemporal dementia

,

primary progressive aphasia

,

post-traumatic stress disorders

,

traumatic stress disorders

,

attention deficit disorder with hyperactivity

,

,

Denileukin diftitox

multiple myeloma

,

,

non-hodgkin lymphoma

,

b-cell lymphoma

,

pancreatic neoplasms

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

t-cell lymphoma peripheral

,

,

t-cell lymphoma cutaneous

,

t-cell lymphoma

,

,

sezary syndrome

,

mycosis fungoides

,

healthy volunteers/patients

,

alzheimer disease

,

cognitive dysfunction

,

,

,

decision support techniques

,

magnetic resonance imaging

Donepezil hydrochloride

healthy volunteers/patients

,

migraine disorders

,

,

,

,

,

parkinson disease

,

alzheimer disease

,

,

cognitive dysfunction

,

lewy body disease

,

cerebrovascular disorders

,

vascular dementia

,

chronic kidney failure

,

kidney diseases

,

memory disorders

,

,

mixed dementias

esophageal neoplasms

,

,

esophageal squamous cell carcinoma

,

colorectal neoplasms

,

pancreatic ductal carcinoma

,

biliary tract neoplasms

,

urologic neoplasms

,

transitional cell carcinoma

,

non-muscle invasive bladder neoplasms

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

breast neoplasms

,

endometrial neoplasms

,

,

uterine cervical neoplasms

,

,

ovarian neoplasms

,

fallopian tube neoplasms

colorectal neoplasms

,

hepatocellular carcinoma

,

,

liver neoplasms

,

neoplasm metastasis

type 2 diabetes mellitus

1

2

3

4

5

6

...

12

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use